ArticleInternational journal of hematology2017

Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.

Koung Jin Suh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.